Birth weight and prenatal exposure to polychlorinated biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE): a meta-analysis within 12 European Birth Cohorts by Govarts, E. et al.
162 volume 120 | number 2 | February 2012 • Environmental Health Perspectives
Review
From the 1930s, polychlorinated biphenyls 
(PCBs) have been manufactured in large quan-
tities for use in many industrial applications 
until they were banned in most countries in 
the 1970s. Dichlorodiphenyltrichloroethane 
(DDT) is a pesticide that since the 1940s has 
been used worldwide for malaria vector con-
trol, and it is still in use in some areas (Aneck-
Hahn et al. 2007; Ayotte et al. 2001). PCBs 
and the main DDT metabolite dichloro-
diphenyldichloroethylene (p,p´-DDE) bio-
accumulate in fat tissues, biomagnify through 
the food chain, are highly persistent in liv-
ing organisms, and comprise the bulk of 
organochlorine residues in human tissues 
(Longnecker et al. 2003). The concentrations 
of these chemicals in blood, fat, and milk have 
decreased over the past 30 years but are still 
detectable in blood of the general population 
all over the globe (Jonsson et al. 2005). It 
has been suggested that organochlorines may 
interfere with fetal growth through interac-
tion with endogenous steroid hormone signal-
ing (Faroon and Olson 2000; Lopez-Espinosa 
et al. 2009). Birth weight restriction related 
to PCBs was first described in humans after 
the 1968 Yusho incident in Japan, where 
thousands of pregnant women were intoxi-
cated by PCB-contaminated cooking rice oil 
(Yamashita and Hayashi 1985). During the 
past 15 years, additional research has addressed 
human reproductive toxicity of PCBs in stud-
ies of fishing communities, fish eaters, and 
the general population in various regions, as 
reviewed by Toft et al. (2004) and Longnecker 
et al. (2003). Findings from these studies on 
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Objectives: Exposure to high concentrations of persistent organochlorines may cause fetal toxicity, 
but the evidence at low exposure levels is limited. Large studies with substantial exposure contrasts 
and appropriate exposure assessment are warranted. Within the framework of the EU (European 
Union) ENRIECO (ENvironmental Health RIsks in European Birth Cohorts) and EU OBELIX 
(OBesogenic Endocrine disrupting chemicals: LInking prenatal eXposure to the development of 
obesity later in life) projects, we examined the hypothesis that the combination of polychlorinated 
biphenyls (PCBs) and dichlorodiphenyldichloroethylene (DDE) adversely affects birth weight.
MethOds: We used maternal and cord blood and breast milk samples of 7,990 women enrolled in 
15 study populations from 12 European birth cohorts from 1990 through 2008. Using identical vari‑
able definitions, we performed for each cohort linear regression of birth weight on estimates of cord 
serum concentration of PCB‑153 and p,p´‑DDE adjusted for gestational age and a priori selected 
covariates. We obtained summary estimates by meta‑analysis and performed analyses of inter actions.
Results: The median concentration of cord serum PCB‑153 was 140 ng/L (range of cohort medians 
20–484 ng/L) and that of p,p´‑DDE was 528 ng/L (range of cohort medians 50–1,208 ng/L). Birth 
weight decreased with increasing cord serum concentration of PCB‑153 after adjustment for poten‑
tial confounders in 12 of 15 study populations. The meta‑analysis including all cohorts indicated 
a birth weight decline of 150 g [95% confidence interval (CI): –250, –50 g] per 1‑µg/L increase in 
PCB‑153, an exposure contrast that is close to the range of exposures across the cohorts. A 1‑µg/L 
increase in p,p´‑DDE was associated with a 7‑g decrease in birth weight (95% CI: –18, 4 g).
cOnclusiOns: The findings suggest that low‑level exposure to PCB (or correlated exposures) 
impairs fetal growth, but that exposure to p,p´‑DDE does not. The study adds to mounting evi‑
dence that low‑level exposure to PCBs is inversely associated with fetal growth. 
Key wORds: birth cohort studies, DDE, gestational age, meta‑analysis, PCBs, reproductive effects. 
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the relation between maternal PCB exposure 
and birth weight are not consistent—some 
indicating an inverse association (Fein et al. 
1984; Karmaus and Zhu 2004; Murphy et al. 
2010; Patandin et al. 1998; Rylander et al. 
1995, 1996, 1998; Wojtyniak et al. 2010), an 
inverse association among male infants only 
(Sonneborn et al. 2008), a positive associa-
tion (Dar et al. 1992), or no association at all 
(Gladen et al. 2003; Grandjean et al. 2001; 
Longnecker et al. 2005; Mendez et al. 2010; 
Vartiainen et al. 1998).
A large U.S. study of women giving birth 
between 1959 and 1966 (when DDT was still 
being used) found a dose–response relation-
ship between DDE concentration in mater-
nal serum and low birth weight (Longnecker 
et al. 2001). Children in the high exposure 
group (> 60 ng/g) weighed 150 g less and 
were born about 1 week earlier than the chil-
dren in the low exposure group (< 15 ng/g). 
Similar results were observed in an Indian 
study of pregnant women with high DDT 
exposures (Siddiqui et al. 2003), but serum 
DDT and/or DDE was not associated with 
birth weight in two other studies (Gladen 
et al. 2003; Wojtyniak et al. 2010).
Many factors may contribute to the 
discrepant findings in earlier observational 
studies of reproductive effects of PCBs. This 
includes correlations in some populations 
between persistent organochlorines (POCs) 
and such dietary nutrients as n-3 fatty acids 
that may increase gestational age (Grandjean 
et al. 2001), limited study size, insufficient 
exposure levels or contrasts between com-
pared populations (Wojtyniak et al. 2010), 
exposure to different mixtures of PCB con-
geners (Murphy et al. 2010), confounding 
by other organochlorines such as hexachloro-
benzene (HCB) (Eggesbo et al. 2009), and 
different susceptibility of studied popula-
tions (Sonneborn et al. 2008). Publication 
bias could also be a problem, with studies not 
finding an association being underreported. 
A recent review concluded that large-scale 
studies with a sufficient number of partici-
pants in well-defined groups with substantial 
exposure contrast are needed to further elu-
cidate the possible adverse effects of POCs 
on human reproductive health (Toft et al. 
2004). The ENRIECO (ENvironmental 
Health RIsks in European birth COhorts) 
framework of European birth cohorts and 
the cohorts included in the EU (European 
Union) OBELIX (OBesogenic Endocrine dis-
rupting chemicals: LInking prenatal eXposure 
to the development of obesity later in life) 
project provide the basis for such a study.
The objective of this study was to exam-
ine associations between biological markers 
of exposure to POCs and birth weight in 
12 European birth cohorts, including possible 
modifying effects of sex and tobacco smoking.
Methods
Description of the cohorts. The ENRIECO 
project has provided an inventory of 
European birth cohorts that aim to inves-
tigate the impact of environmental expo-
sures on health in pregnancy and early 
childhood. Among these cohorts, we iden-
tified 14 cohorts of pregnant women with 
individual measurements of PCB-153 and 
p,p´-DDE. One invited cohort declined par-
ticipation for reasons not related to current 
hypotheses, and we excluded one cohort 
that used placenta tissue samples for expo-
sure assessment [the Finnish LUKAS cohort 
(Karvonen et al. 2009)]. Each cohort tar-
geted the general population and included 
births from 1990 to 2008. We divided 
the INMA (INfancia y Medio Ambiente; 
Environment and Childhood) cohort into 
two populations based upon the matrix used 
for POC measurements (maternal serum or 
cord serum) and divided the INUENDO 
cohort into three populations (Greenland; 
Warsaw, Poland; and Kharkiv, Ukraine) 
resulting in 15 study populations with a total 
of 7,990 live-born singletons with PCB-153 
measure ments and 7,788 live-born singletons 
with p,p´-DDE measurements (Table 1). 
The concentrations of PCBs and p,p´-DDE 
were analyzed in maternal serum or whole 
blood collected during pregnancy (seven 
populations), cord serum or plasma (five 
populations), or breast milk (three popula-
tions). Detailed information regarding the 
study cohorts are provided in Table 1 and 
Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1103767).
Exposure assessment. Analysis of PCB‑153 
and p,p´‑DDE. We used PCB-153 as a bio-
marker of PCB exposure because concen-
trations of this PCB congener are relatively 
high and highly correlated with the total 
molar concentration of PCBs (Glynn et al. 
2000; Muckle et al. 2001; Needham et al. 
2011). The elimination half-life of PCB-153 
is > 10 years (Ritter et al. 2011 and that of 
p,p´-DDE, the major metabolite of DDT, is 
approximately 5 years (Ferreira et al. 2011).
To facilitate comparisons of results from 
cohorts using different matrices for exposure 
assessment, we expressed all contaminant levels 
as wet weight cord serum levels, which directly 
reflect fetal exposure at the time of delivery 
(some compounds do not cross the placenta 
efficiently). For populations that did not have 
cord blood analyses, we estimated concentra-
tions in cord serum from the concentrations 
measured in maternal serum (FAROES2, 
INMA, INUENDO, and RHEA), maternal 
whole blood (DUISBURG), or breast milk 
[FAROES3, HUMIS (Norwegian Human 
Milk Study), and ELFE (Growing up in 
France) pilot], using the following conver-
sion factors [for details, see Supplemental 
Material, pp. 2–3 (http://dx.doi.org/10.1289/
ehp.1103767)]:
Cord serum level (ng/L) =  
0.20 × maternal serum level (ng/L)
Cord serum level (ng/L) =  
1.20 × breast milk level (ng/g fat)
Cord serum level (ng/L) =  
0.36 × maternal whole blood level (ng/L).
We compi led  informat ion about 
 chemical-analytical methods and their detec-
tion limits [see Supplemental Material, Table 2 
(http://dx.doi.org/10.1289/ehp.1103767)]. 
High-quality analytical data were available for 
both PCB-153 and p,p´-DDE in each cohort 
except the GRD (Groningen–Rotterdam–
Düsseldorf) and ELFE pilot cohorts, where 
only PCB-153 was measured. Spearman cor-
relation coefficients between PCB-153 and 
p,p´-DDE in the cohorts ranged from 0.3 to 
almost 1, with a median of 0.6.
Outcome variable and covariates/ 
confounders. The outcome of interest was birth 
weight, which was extracted from medical 
records. Covariate data were obtained from 
questionnaires and medical record informa-
tion for children and their mothers, including 
information from antenatal health care visits. 
Gestational age was estimated from the date of 
the last menstrual period and/or by ultrasound. 
For five study populations, the data obtained 
from the last menstrual period were replaced 
by ultrasound determination if the discrep-
ancy between the two techniques exceeded 
7–14 days [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1103767)]. 
All participants completed an extensive ques-
tionnaire themselves or by a telephone or 
face-to-face interview, assessing information 
on lifestyle, diet, use of tobacco and alcohol, 
residence history, health, education, hobbies, 
and occupation (if applicable). Each study 
was approved by appropriate national ethi-
cal committees, and mothers provided written 
informed consent for participation.
Statistical analysis. We developed a 
uniform script in SAS version 9.1 (SAS Institute 
Inc., Cary, NC, USA) and SPSS versions 
17.0 and 18.0 (SPSS, Chicago, IL, USA) to 
define the variables, units, and categories used 
in statistical analyses for each of the 11 study 
centers. We allowed cohort specific variables 
for region and socioeconomic status. For some 
important confounders, missing values were 
replaced by the most frequent outcome for the 
study population. Specifically, missing data 
for smoking and alcohol consumption were 
replaced by nonsmoking/nondrinker, except 
for (in the INUENDO cohort) Greenland, 
where mothers with missing data for smoking 
were assumed to be smokers, and Warsaw, 
Govarts et al.
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Table 1. Description of the ENRIECO/OBELIX birth cohorts with biological PCB‑153/p,p´‑DDE exposure biomarkers included in the present study.
Cohort
Setting 
location
 
Time period Enrollment method
 
Only 
babies 
at term?
 
Other exclusion criteria
 
Participation 
rate
Exposure assessment 
Main reference
Selection criteria 
for exposure 
assessment
na
Biological 
matrix
Time of 
collection
PCB-
153
p,p´- 
DDE
GRD The 
Netherlands 
(Groningen–
Rotterdam)
1990–1992 During prenatal 
consultations in 
late pregnancy by 
obstetricians or 
midwifes
Yes Serious illness 
during pregnancy; 
congenital 
anomalies; white 
race; parity > 2; 
cesarean section
70% Availability of 
biological 
samples
Cord 
plasma
At birth 382 — Huisman et al. 
1995
 Germany 
(Düsseldorf)
1993–1995 At delivery from the 
obstetrical wards 
of three Düsseldorf 
hospitals by three 
medical students
Yes Serious illness 
during pregnancy; 
congenital 
anomalies; native 
German families; 
parity > 2; cesarean 
section
70% Availability of 
biological 
samples
Cord 
serum
At birth 141 — Walkowiak 
et al. 2001
FAROES2 
(cohort 2)
Faroe Islands 1994–1995 Consecutive births at 
the National Hospital 
in Torshavn, but from 
women living away 
from the capital area 
of Torshavn
No Serious congenital 
disease
64% Availability of 
biological 
samples
Maternal 
serum
Week 34 
(from 
antenatal 
consultation)
173 173 Steuerwald 
et al. 2000
FAROES3 
(cohort 3)
Faroe Islands 1997–2000 Consecutive pregnant 
women
No Serious congenital 
disease
60% Breast-feeding Breast 
milk
Days 3–5 and 
at 2 weeks
596 596 Weihe et al. 
2003
INMA Spain 
(Menorca)
1997–1999 During prenatal care at 
general practices of 
the island (in public or 
private health centers)
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
98% Availability of 
biological 
samples
Cord 
serum
At birth 404 405 Carrizo et al. 
2006
Spain 
(Granada)
2000–2002 During hospital 
admission for delivery 
in the study area
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
Unknown Availability of 
biological 
samples
Cord 
serum
At birth — 318 Ribas-Fito et al. 
2006
Spain 
(Valencia)
2004–2005 During the first prenatal 
visit in the main public 
hospital or health 
center of the study 
area
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
54% Availability of 
biological 
samples
Cord 
serum
At birth 499 499 Vizcaino et al. 
2010
Spain 
(Sabadell)
2004–2006 During the first prenatal 
visit in the main public 
hospital or health 
center of the study 
area
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
60% Availability of 
biological 
samples
Maternal 
serum
Week 13 of 
pregnancy
605 605 Ribas-Fito et al. 
2006
Spain 
(Asturias)
2004–2007 During the first prenatal 
visit in the main public 
hospital or health 
center of the study 
area
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
45% Availability of 
biological 
samples
Cord 
serum
At birth 25 25 Ribas-Fito et al. 
2006
 Spain 
(Gipuzkoa)
2006–2008 During the first prenatal 
visit in the main public 
hospital or health cen-
ter of the study area
No Maternal age 
< 16 years; to 
have followed any 
program of assisted 
reproduction; no 
wish to deliver in the 
reference hospital; 
speaking difficulties
68% Availability 
of biological 
samples
Maternal 
and cord 
serum
Week 13.5 of 
pregnancy 
and at birth
604 605  Ribas-Fito et al. 
2006
DUISBURG Germany 
(Duisburg)
2000–2002 Self-selected pregnant 
women within a 
predefined area mainly 
in Duisburg South
Yes Nonhealthy mother–
infant pairs; babies 
not from German- or 
Turkish-speaking 
families; Apgar score 
< 8; parity > 3
Unknown Availability of 
biological 
samples
Maternal 
blood
32nd week of 
pregnancy
189 189 Wilhelm 
et al. 2008; 
Wittsiepe 
et al. 2008
continued next page
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where mothers with missing data for alcohol 
were assumed to be moderate drinkers. For 
continuous variables (e.g., maternal height) 
missing values were replaced with the 
population-specific median.
In all 15 study populations, PCB-153 and 
p,p´-DDE were detected in at least 78% of 
subjects, and in 11 populations both com-
pounds were detected in > 95% of samples 
(Table 2). We replaced values below the limit 
of detection (LOD) or quantification (LOQ) 
by the LOD or LOQ divided by the square 
root of two (Hornung and Reed 1990).
We developed separate multiple lin-
ear regression models to estimate the asso-
ciation between birth weight and PCB-153 
or p,p´-DDE concentrations in cord serum. 
Several known determinants of birth weight 
were included in the models regardless of 
actual degree of confounding of the POC–
birth weight association in the individual 
cohorts (Bailey and Byrom 2007; Goldenberg 
et al. 1997). These included gestational age 
(weeks, linear and quadratic terms), off-
spring sex (male/female), region (cohort-spe-
cific categories), maternal body mass index 
(BMI; < 18.5 kg/m², 18.5 ≤ 25 kg/m², 25 
≤ 30 kg/m², and ≥ 30 kg/m²), height (con-
tinuous), smoking status during pregnancy 
(non-smoking, smoking ≤ 9 cigarettes/day, 
smoking > 9 cigarettes/day), socioeconomic 
status (cohort-specific categories), mother’s 
age (< 25 years, 25–29 years, 30–34 years, and 
≥ 35 years), parity (0, 1, and ≥ 2), ethnicity 
(cohort-specific categories), and gestational age 
at time of sampling (first, second, and third 
trimester and postnatal). We evaluated sex and 
smoking status as potential effect modifiers 
based on literature regarding PCB exposure 
Table 1. continued.
Cohort
Setting 
location
 
Time period Enrollment method
 
Only 
babies 
at term?
 
Other exclusion criteria
 
Participation 
rate
Exposure assessment 
Main reference
Selection criteria 
for exposure 
assessment
na
Biological 
matrix
Time of 
collection
PCB-
153
p,p´- 
DDE
FLEHSI Belgium 
(Flanders)
2002–2004 At delivery in 
maternities of eight 
districts covering 20% 
of Flanders’ area
No Complications in 
delivery; living 
< 5 years in the area; 
not Dutch reading
98% Availability of 
biological 
samples
Cord 
plasma
At birth 1,068 1,114 Koppen et al. 
2009
INUENDO Greenland 2002–2004 By the local midwife 
when visiting the 
local hospital or 
health clinic from 15 
municipalities of all 
regions in Greenland
No Maternal age 
< 18 years; not born 
in the country
90% Availability of 
biological 
samples
Maternal 
serum
24 weeks on 
average
546 546 Toft et al. 2005
Poland 
(Warsaw)
2003–2004 During antenatal classes 
at the obstetric 
outpatient clinic of the 
Gynaecological and 
Obstetric Hospital of 
the Warsaw School 
of Medicine or with 
physicians at a 
collaborating hospital 
in the same city
No Maternal age < 18 
years; not born in the 
country
68% Availability of 
biological 
samples
Maternal 
serum
33 weeks on 
average
199 199 Toft et al. 2005
 Ukraine 
(Kharkiv)
2003–2004 During visit of one of 
eight antenatal clinics 
or three maternity 
hospitals in Kharkiv by 
gynecologists
No Maternal age 
< 18 years; not born 
in the country
26% Availability of 
biological 
samples
Maternal 
serum
24 weeks on 
average
589 589  Toft et al. 2005
Michalovce Slovakia 2002–2004 At delivery in 
maternities of two 
districts, one with high 
contamination of PCBs 
(Michalovce), and 
another one upwind 
and upstream of the 
chemical facility with 
lower contamination 
levels (Svidnik).
No Mothers with 
major illness; 
severe congenital 
anomalies; maternal 
age < 18 years; living 
< 5 years in the area; 
parity > 4
60% Availability of 
biological 
samples
Cord 
serum
At birth 1,082 1,082 Hertz-Picciotto 
et al. 2003
HUMIS Norway 2002–2006 2–4 weeks after birth 
during the routine 
health visit at home
No Non-fluent in 
Norwegian
64% Random selection 
in the cohort; 
breast-feeding
Breast 
milk
Milk sampled 
on 8 
consecutive 
days and 
pooled
418 418 Eggesbo et al. 
2009
PELAGIE France 
(Brittany)
2002–2006 During first prenatal 
visit by gynecologists 
or obstetricians in the 
study area
No Inclusion later 
than 19 weeks of 
pregnancy
80% Stratified random 
selection of 
a subcohort 
among the live 
born cohort; 
availability 
of biological 
samples
Cord 
serum
At birth 396 395 Petit et al. 2010
ELFE pilot France 2007 At delivery in maternity 
department
No Maternal age < 18 
years; not French 
speaking; parity > 2
55% Breast-feeding Breast 
milk
1 month after 
birth
44 — Vandentorren 
et al. 2009 
RHEA Greece 
(Heraklion, 
Crete)
2007–2008 Contact by interviewer 
of all pregnant women 
living in Heraklion 
around 12 weeks of 
gestation
No Maternal age 
< 18 years; insufficient 
understanding of the 
Greek language
72% Random  selection 
of a small 
subcohort
Maternal 
serum
 During 
the first 
interview
30 30 Vardavas et al. 
2010
aNumber of liveborn singleton births with exposure levels. 
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and growth or development (Hertz-Picciotto 
et al. 2005; Verhulst et al. 2009), and we also 
examined interaction between PCB-153 and 
p,p´-DDE. Effect modification (interaction) 
was analyzed in models including main effects 
and cross-product terms. A p-value < 0.05 
for the effect of the cross-product was taken 
as an indication of interaction. Finally, we 
examined associations of gestational age with 
PCB-153 and p,p´-DDE in cord serum by lin-
ear regression to determine if associations with 
birth weight might be mediated by effects on 
gestational age.
We checked assumptions of normality, 
constancy of variance, independence (ran-
domness), and linearity with informal diag-
nostic plots and formal tests [White’s General 
test for constancy of variance (White 1980), 
Kolmogorov–Smirnov test for normality, and 
the lack of fit test for linearity (Neter et al. 
1996)] and fitted regression models with and 
without influential outliers.
We used meta-analyses to estimate the 
overall summary effects of levels of PCB-153 
and p,p´-DDE in cord serum on birth weight 
using R version 2.11.0 (R Foundation for 
Statistical Computing, Vienna, Austria). First, 
we tested for heterogeneity between effect 
estimates using the Q-test (Cochran 1954). If 
the result of the Q-test was statistically signifi-
cant (p < 0.05), an indication of heterogeneity 
across populations, we used random effects 
analyses (DerSimonian and Laird 1986). In 
addition, because the Q-test has low statistical 
power with few studies (Hardy and Thompson 
1998), we also used the I 2 to assess heterogene-
ity (Higgins and Thompson 2002). Following 
the thresholds provided by Deeks et al. (2008), 
we interpreted an I 2 > 30% as reflecting at least 
moderate heterogeneity. Therefore, when the 
Q-test was not statistically significant, but the 
I 2 > 30% we also used a random effects model. 
Using this approach we observed significant 
heterogeneity across study populations for the 
PCB-153 association (p = 0.01) and there-
fore we used a random effects model for all 
analyses. Summary estimates were weighted by 
the inverse variance of each cohort. To deter-
mine the influence of any particular popula-
tion, we repeated the meta- analyses leaving one 
 population out at the time.
Results
The median birth weight ranged from 3,210 
to 3,750 g, and median gestational age from 
38 to 40 weeks. The proportion of cesarean 
sections was below 25% in all populations 
except RHEA (43.3%) [see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1103767)]. In five populations, > 20% of 
mothers were < 25 years of age at delivery and 
in two populations > 20% were > 35 years of 
age. The proportion of nulliparous women 
exceeded 40% in nine of the populations.
The median concentration of PCB-153 
in cord serum in the 15 study populations 
ranged from 20 to 484 ng/L [Table 2; also 
see Supplemental Material, Figure 1 (http://
dx.doi.org/10.1289/ehp.1103767)]. The 
median cord serum PCB-153 concentra-
tion in the Faroese population was 3.4 times 
higher than the overall median of 140 ng/L. 
The populations with the lowest median 
PCB-153 concentrations in cord serum (e.g. 
Warsaw, Kharkiv, HUMIS, and RHEA) also 
had a narrow range of concentrations com-
pared with the other populations (range from 
the 10th to the 90th percentiles: 7–83 ng/L 
compared with 14–1,302 ng/L).
The median level of p,p´-DDE in cord 
serum in the 15 populations ranged from 50 
to 1,208 ng/L [Table 2; also see Supplemental 
Material, Figure 2 (http://dx.doi.org/10.1289/
ehp.1103767)]. The median cord serum 
p,p´-DDE concentration in the Faroese popu-
lation was 2.2 times higher than the overall 
median of 528 ng/L.
Gestational ages ranged from 25–44 
weeks [see Supplemental Material, Table 1 
(http://dx.doi.org/10.1289/ehp.1103767)]. 
Associations between POC concentrations and 
gestational age, including preterm births, were 
not statistically significant for any of the indi-
vidual populations (data not shown) or in the 
meta-analysis [for PCB-153: β = 6.2 × 10–6; 
95% confidence interval (CI): –2.5 × 10–5, 
3.7 × 10–5, p = 0.18; for p,p´-DDE: β = 
–1.2 × 10–5; 95% CI: –4.8 × 10–5, 2.5 × 10–5), 
p = 0.40]. 
There was a statistically significant inverse 
association between PCB-153 concentrations 
in cord serum and birth weight in four popu-
lations (GRD, INMA cord, FLEHSI, and 
Greenland) (Figure 1).
The meta-analysis showed a statisti-
cally significant inverse association between 
PCB-153 concentrations in cord serum 
and birth weight, corresponding to a 150-g 
(95% CI: –240, –50 g) reduction per 1-µg/L 
increase in cord serum PCB-153 (Figure 1). 
A sensitivity analysis restricted to 3,856 nulli-
parous women produced a combined esti-
mate of similar magnitude (β = –152 g/µg 
PCB-153; 95% CI: –341, 37, p = 0.12 [see 
Supplemental Material, Table 3 (http://dx.doi.
org/10.1289/ehp.1103767)]. Analyses leav-
ing out one popu lation at the time did not 
show qualitatively different results from those 
reported (data not shown). In the meta-
 regression, biological sample matrix (cord 
serum, maternal blood/serum, or milk), time 
period (1990–1999/2000–2008), geographic 
area (FAROES2, FAROES3, Greenland, and 
HUMIS vs. other cohorts), and fish consump-
tion (FAROES2, FAROES3, and Greenland) 
versus other cohorts were not significant 
Table 2. Concentration of PCB‑153 and p,p´‑DDE (ng/L) exposure biomarkers in cord serum, actual or obtained by conversion, of the ENRIECO/OBELIX birth 
cohorts.
PCB-153 (ng/L) p,p´-DDE (ng/L)
Cohort n Mean ± SD Median n < LOD/LOQ n Mean ± SD Median n < LOD/LOQ
GRDa 523 170.6 ± 99.7 150.0 0 — — — —
FAROES2b 167 648.4 ± 580.0 484.2 2 (1.2%) 167 1708.3 ± 1433.9 1208.0 0
FAROES3c 549 434.4 ± 347.6 345.6 0 549 987.7 ± 994.9 729.6 0
INMA corda 1,227 156.1 ± 112.7 134.1 114 (9.3%) 1,515 1,380 ± 2269.8 596.0 57 (3.8%)
INMA matb 856 52.8 ± 34.7 46.4 56 (6.5%) 857 262.6 ± 1030.0 131.2 5 (0.6%)
DUISBURGb 189 147.1 ± 99.4 124.0 0 189 323.7 ± 435.6 216.0 0
FLEHSIa 1,015 73.3 ± 56.7 60.0 202 (19.9%) 1,061 315.6 ± 344.6 220.0 19 (1.8%)
Greenlandb 546 253.8 ± 341.9 155.1 7 (1.3%) 546 634.6 ± 684.2 435.7 10 (1.8%)
Warsawb 199 23.8 ± 17.8 20.1 43 (21.6%) 199 824.7 ± 518.3 668.8 0
Kharkivb 577 45.8 ± 36.3 37.1 20 (3.5%) 577 1100.8 ± 762.3 916.3 0
Michalovcea 1,036 393.5 ± 458.3 271.8 2 (0.2%) 1,036 1329.5 ± 1338.4 1014.7 8 (0.8%)
HUMISc 409 43.1 ± 20.0 39.2 0 409 75.0 ± 111.0 49.8 0
PELAGIEa 396 126.1 ± 77.7 110.0 2 (0.5%) 395 253.3 ± 335.8 180.0 76 (19.2%)
ELFE pilotc 43 100.4 ± 52.7 92.5 0 — — — —
RHEAb 30 28.0 ± 13.4 23.8 0 30 573.2 ± 389.2 496.0 0
Combined 7,762 179.8 ± 156.6 139.6 448 (5.8%) 7,530 751.5 ± 819.1 527.9 175 (2.3%)
mat, maternal serum. 
aObserved cord serum concentrations and bestimated cord serum concentrations based on measured concentrations in maternal serum (whole blood for DUISBURG) or cbreast milk 
[for additional information on conversions, see Supplemental Material, pp. 2–3 (http://dx.doi.org/10.1289/ehp.1103767)].
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predictors of heterogeneity among the study 
populations (data not shown). Separate meta-
analytic regressions by sample matrix were 
consistent with the overall combined estimate 
for maternal serum (β = –120 g/µg PCB-143; 
95% CI: –260, 10), stronger for the com-
bined estimate for cord serum (β = –290 g/µg 
PCB-143; 95% CI: –540, –40) and weaker for 
breast milk (β = –50 g/µg PCB-143; 95% CI: 
–160, 50).
The meta-analysis of the relation between 
cord serum p,p´-DDE and birth weight 
(Figure 2) did not indicate a statistically sig-
nificant association (7-g reduction per 1-µg/L 
increase in cord serum p,p´-DDE; 95% CI: 
–18, 4). Analyses leaving one cohort out at 
a time did not show qualitatively different 
results. Separate meta-analytic regressions 
by sample matrix were consistent with the 
overall result and did not show an association 
between p,p´-DDE and birth weight (data 
not shown).
Associations of birth weight with PCB-153 
and p,p´-DDE were not modified by sex or 
smoking (data not shown). Associations were 
also comparable when lipid-adjusted POC 
concentrations were modeled and when expo-
sures were modeled using quadratic and log-
linear transformation (data not shown). The 
expected associations between birth weight and 
sex (higher birth weight for males compared to 
females), tobacco smoking (smoking during 
pregnancy leading to lower birth weight) and 
body mass index (mothers with a high BMI 
have babies with higher birth weights) were 
demonstrated in all cohorts (data not shown). 
A sensitivity analysis restricted to infants 
born at term (e.g., gestational age between 37 
and 42 weeks) showed no material changes 
in effect estimates (data not shown). When 
adjusting for p,p´-DDE in the models, the 
inverse association between PCB-153 and 
birth weight was not altered, and no signifi-
cant interaction was found between PCB-153 
and p,p´-DDE on birth weight within the 
cohorts (data not shown).
Discussion
In our meta-analysis of 12 European birth 
cohorts (15 study populations) we observed 
decreases in birth weight independent of ges-
tational age with increasing fetal PCB-153 
concentrations. Across all cohorts birth weight 
declined by 150 g in association with a 1-µg/L 
increase of PCB-153 in cord serum—an expo-
sure contrast that is close to the range of expo-
sure levels across the cohorts. In magnitude, 
this association is comparable to the associa-
tion between birth weight and smoking about 
10 cigarettes per day during pregnancy, and 
Figure 1. Adjusted regression coefficients (95% CI) of cord serum PCB‑153 (ng/L) with birth weight (g). The squares are proportional to the inverse variance of 
the effect estimation of each cohort. Covariates included in the regression model: child’s gestational age and sex, mother’s region, maternal BMI, height, smok‑
ing status during pregnancy, socioeconomic status, mother’s age, parity, and ethnicity, and time of sampling. Greenland, Warsaw, and Kharkiv are part of the 
INUENDO cohort.
–20 –4 –2 2 4 400
  No. of 
Study β (95% CI) subjects
GRD −0.386 (−0.758, −0.014)  523 
FAROES2 −0.070 (−0.182, 0.042)  167 
FAROES3 −0.054 (−0.158, 0.050)  549 
INMA cord −0.319 (−0.531, −0.107)  1,222 
INMA mat −0.037 (−0.868, 0.794)  854 
DUISBURG  −0.630 (−1.332, 0.072)  189 
FLEHSI −0.659 (−1.133, −0.185)  1,000 
Greenland −0.190 (−0.313, −0.067)  545 
Warsaw −0.067 (−3.758, 3.624)  196 
Kharkiv 0.675 (−0.168, 1.518)  573 
Michalovce  −0.012 (−0.067, 0.043) 978 
HUMIS  −1.294 (−3.867, 1.279)  409 
PELAGIE  −0.322 (−0.857, 0.213)  393 
ELFE pilot  0.569 (−1.797, 2.935)  43 
RHEA  11.274 (−20.888, 43.436)  25 
Combined effect (random)  −0.15 (−0.24, −0.05)  7,666
Figure 2. Adjusted regression coefficients (95% CI) of cord serum p,p´‑DDE (ng/L) with birth weight (g). The squares are proportional to the inverse variance of the 
effect estimation of each cohort. For model covariates, see Figure 1. Greenland, Warsaw, and Kharkiv are part of the INUENDO cohort.
–0.5 0.0 0.5
    No. of
Study β (95% CI) subjects
FAROES2  −0.017 (−0.062, 0.0281)   167
FAROES3  −0.022 (−0.057, 0.0133)   549
INMA cord  −0.005 (−0.015, 0.0048)   1,505
INMA mat  0.012 (−0.013, 0.0375)   855
DUISBURG  −0.089 (−0.240, 0.0619) 189
FLEHSI  0.034 (−0.037, 0.1046) 1,044
Greenland   −0.071 (−0.132, −0.0102) 545
Warsaw   −0.107 (−0.225, 0.0106) 196
Kharkiv  0.014 (−0.027, 0.0552) 573
Michalovce  −0.010 (−0.030, 0.0096) 978
HUMIS  −0.149 (−0.566, 0.2685) 409
PELAGIE  0.012 (−0.100, 0.1237) 392
RHEA  0.010 (−0.721, 0.7411) 25
Combined effect (random) −0.007 (−0.018,  0.004) 7,427
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more pronounced than the association with 
exposure to environmental tobacco smok-
ing, which, according to a review of several 
earlier studies and meta-analyses, confers an 
average reduction in birth weight of 30–40 g 
(Lindbohm et al. 2002). If the observed asso-
ciations are causal, effects attributable to PCB 
exposure may be clinically relevant in the 
studied populations.
In contrast, we found no indications 
that fetal exposure to the DDT metabolite 
p,p´-DDE was related to birth weight, which 
is consistent with results of a large study 
based on the U.S. National Collaborative 
Perinatal Project (CPP) (Longnecker et al. 
2001) that examined children born 1959–
1966, before DDT was banned in the 
United States. Although results of the CPP 
study strongly suggested that DDT expo-
sure was related to preterm birth and small 
for gestational age babies, no association was 
detected with maternal serum concentrations 
< 10 µg/L (corresponding to a concentration 
of 2.5 µg/L in cord serum), which is higher 
than DDE concentrations in > 95% of preg-
nant women participating in our study [see 
Supplemental Material, Figure 2 (http://
dx.doi.org/10.1289/ehp.1103767)].
Fish is an important source of PCB 
exposure in communities with a high sea-
food intake (Thorsdottir et al. 2004), but fish 
meals also contribute substantially to internal 
PCB levels in other populations (Halldorsson 
et al. 2008). Fatty fish contains n-3 poly-
unsaturated fatty acids (PUFA) that in a ran-
domized controlled trial have been shown to 
prolong gestation and increase birth weight 
(Olsen et al. 2007). A study of a representa-
tive sample of Danish pregnant women that 
explicitly addressed competitive effects of n-3 
polyunsaturated fatty acids and organochlo-
rine contaminants in seafood did not indicate 
that the effects on birth weight of the PUFA 
outweighed possible deleterious effects of 
PCBs or other contaminant exposures in the 
study population (Halldorsson et al. 2008). 
Because the balance of effects is determined 
by the relative exposure levels, these findings 
may not apply to populations consuming 
other types of seafood. Other studies have 
not observed associations between PCBs and 
birth weight after adjusting for marine n-3 
fatty acids (Grandjean et al. 2001). Accurate 
information on fish intake was not available 
in all cohorts. In general, we would expect 
residual confounding due to nondifferen-
tial misclassification of fish consumption to 
bias the association between PCBs and birth 
weight upward. Therefore, it seems unlikely 
that misclassification would cause the inverse 
association that we observed. In addition, fish 
consumption did not appear to contribute to 
heterogeneity across the cohorts. It is possible, 
however, that the misclassification might have 
been related to other sources of error and pos-
sibly to exposure, given that it varied among 
the cohorts such that any resulting bias might 
differ from expectations.
The PCB congener mixture in human 
tissues depends on the source of exposure 
and the time of sampling relative to exposure 
(Faroon and Olson 2000). Because PCB 
congeners vary in toxicity, differences in PCB 
congener profiles across populations may 
result in differences in effects on birth weight 
(if any) and explain some of the heterogeneity 
of the effect estimates. Although PCB-153 
was highly correlated with the non-dioxin-like 
PCB-138 and PCB-180 in all cohorts (r-values 
ranging from 0.79 to 0.99), the association 
with the dioxin-like PCB-118 was weaker 
[r-values ranging from 0.23 to 0.83 except in 
the Faroese [r = 0.94 for FAROES2 and 0.90 
for FAROES3, respectively (Grimvall et al. 
1997)]. Other biopersistent organochlorines 
that are correlated with PCB-153, such as 
dioxins, hexachlorobenzene (Eggesbo et al. 
2009), hexachlorocyclohexane, dieldrin, and 
others (Longnecker et al. 2005) may add to 
the observed heterogeneity. It is not possible 
to examine possible differential effects of 
different mixtures of PCB congeners with 
the available data, but geographic area and 
calendar time of the study did not contribute 
to the observed heterogeneity.
Measurements from cord blood reflect 
exposure at delivery but may not be a good 
marker of exposure in early pregnancy 
(Murphy et al. 2010), and maternal blood 
samples taken in late pregnancy (most sam-
ples in this study) may not truly reflect fetal 
exposure during embryogenesis. In a longitu-
dinal study, Bloom et al. (2007) observed sub-
stantially lower serum concentrations of PCB 
congeners 6 weeks after delivery and in early 
pregnancy compared with the period before 
conception. The magnitude of change from 
early to late pregnancy (if any) is, to the best of 
our knowledge, unknown. Extrapolating fetal 
exposure from breast milk samples is less reli-
able, because exposure assessment is retrospec-
tive and exposure levels decline with time after 
delivery because of elimination through breast 
milk (Redding et al. 2008). On the other 
hand, results of a recent study suggest that 
while variable, the average monthly decrease 
in milk PCB is only 1% (Hooper et al. 2007). 
Thus, the error in exposure introduced by 
using concentrations in milk one month after 
birth as a surrogate for prenatal exposure may 
be limited. We were not able to fully address 
the effects of different sampling times relative 
to pregnancy; but a poor proxy of a causal 
agent is more likely to result in dilution of risk 
estimates and therefore in particular is an issue 
in studies with no associations. 
The conversion of concentrations mea-
sured from maternal serum and breast milk 
into those of cord serum was for descriptive 
purposes only, whereas the meta-analysis was 
based upon within-population regression esti-
mates of exposures that were measured in a 
single biological matrix. We did not attempt 
to perform exposure–response analyses across 
the various populations, and thus did not 
include the absolute values of exposures in the 
meta-analysis.
The specificity of results indicating asso-
ciations of birth weight with PCBs but not 
p,p´-DDE, as well as demonstration of the 
expected associations between birth weight 
and, respectively, infant sex and maternal 
tobacco smoking and BMI, supports the 
validity of findings and suggests that the asso-
ciation between PCB-153 and birth weight 
was not merely an artifact of study design 
or analysis. The correlation between con-
centrations of PCB-153 and p,p´-DDE was 
about 0.6 in most cohorts, but adjustment by 
p,p´-DDE in the individual cohorts did not 
attenuate the inverse association between PCB 
and birth weight, and there was no significant 
interaction between PCB-153 and p,p´-DDE 
on birth weight within or across cohorts.
Are results biased by reverse causation? 
Large maternal weight gain is correlated with 
high birth weight and could reduce POC 
levels because of dilution, thus producing 
an artificially negative association between 
POC concentration and birth weight. The 
much stronger association of PCB-153 than 
p,p´-DDE with birth weight is inconsistent 
with the dilution hypothesis, unless parti-
tioning of PCBs into adipose tissue is greater 
than for DDE. But available data do not 
indicate that placental transfer of DDE devi-
ates from PCBs in average (Needham et al. 
2011). Moreover, in cohorts where data on 
weight gain during pregnancy were avail-
able [INMA and PELAGIE (Perturbateurs 
endocriniens: Étude Longitudinale sur les 
Anomalies de la Grossesse, l’Infertilité et 
l’Enfance)], additional analyses adjusting for 
weight gain during pregnancy did not change 
the risk estimates materially. For instance, for 
the INMA cord subcohort, the weight gain 
unadjusted risk estimate was –0.30 (95% CI: 
–0.57, –0.04) and the weight gain adjusted 
estimate was –0.31 (95% CI: –0.57, –0.05).
The discrepant findings in several earlier 
studies are puzzling (Dar et al. 1992; Fein 
et al. 1984; Gladen et al. 2003; Grandjean 
et al. 2001; Karmaus and Zhu 2004; 
Longnecker et al. 2005; Mendez et al. 2010; 
Murphy et al. 2010; Patandin et al. 1998; 
Rylander et al. 1995, 1996, 1998; Sonneborn 
et al. 2008; Vartiainen et al. 1998; Wojtyniak 
et al. 2010). Among the populations included 
in this meta-analysis, only four showed a sig-
nificant inverse association between PCB-153 
and birth weight, of which one to two might 
be expected as chance findings at the 5% 
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significance level (15 populations and 2 com-
pounds = 30 comparisons). Reasons may be 
inadequate sample sizes, exposure misclas-
sification, or exposure profile heterogeneity. 
However, we acknowledge that more con-
sistent findings in earlier studies and across 
populations in this study would add to the 
credibility of the overall result.
Although the possible mode of action for 
effects of PCBs on birth weight is uncertain, 
the endocrine-disrupting properties of PCBs 
could be involved. Estrogens play a pivotal role 
in promoting fetal growth (Kaijser et al. 2000). 
Both estrogenic and anti-estrogenic activity 
has been observed for non-dioxin-like PCBs 
(NDL-PCBs). A recent study analyzing the 
toxicity profiles of 24 PCB congeners by 
in vitro assays revealed that higher chlorinated 
NDL-PCBs were weak estrogen receptor 
(ER) antagonists, and that several NDL-
PCBs inhibited estradiol-sulfo transferase 
activity (Hamers et al. 2011). Antiestrogenic 
congeners may inhibit fetal growth by 
their intrinsic activity or by disruption of 
endogenous estrogen metabolism. In addition, 
both estrogenic and antiestrogenic activity has 
been observed for hydroxylated metabolites 
of lower chlorinated non-dioxin-like PCBs 
(Connor et al. 1997), which are transferred 
more efficiently through placenta than the 
parent compounds (Park et al. 2008). PCBs 
exhibit also a weak antiandrogenic activity, 
which may also have an impact on fetal 
growth (Luke et al. 2005). Finally, PCBs are 
also known to interfere with thyroid hormone 
status in animals and humans [for reviews see 
Klaassen and Hood (2001) and Brouwer et al. 
(1998)]. In vitro assays showed that several 
NDL-PCBs inhibit estradiol-sulfotransferase 
activity and bound to transthyretin (Hamers 
et al. 2011). It is well known that maternal 
hypothyroidism is related to low birth weight 
(Blazer et al. 2003).
Low birth weight represents a mix of 
preterm delivery and reduced fetal growth. 
Because PCB levels were not associated with 
duration of gestation in either sex, our results 
suggest that PCB dose may be related to birth 
weight restriction rather than preterm deliv-
ery. This hypothesis was corroborated by an 
analysis restricted to infants born at term that 
showed no material changes in effect esti-
mates, consistent with several recent studies 
(Halldorsson et al. 2008; Hertz-Picciotto et al. 
2005; Longnecker et al. 2001; Sonneborn 
et al. 2008).
In two studies, reduced birth weight 
has been observed in association with PCBs 
among boys only (Hertz-Picciotto et al. 2005; 
Sonneborn et al. 2008). This observation 
was not corroborated by our analyses. Earlier 
reports on sex-specific effects are not sup-
ported by animal or mechanistic evidence and 
may represent chance findings.
Conclusion
Our harmonized meta-analysis of 12 
European mother–child cohorts including 
> 7,000 pregnancies suggests that low-level 
PCB exposure (or correlated exposures) 
impairs fetal growth, whereas current lev-
els of p,p´-DDE were not associated with 
birth weight adjusted for gestational age. On 
average, birth weight declined by 150 g per 
1-µg/L increase in PCB-153 cord serum con-
centration. The study adds to the mounting 
evidence that low-level exposure to PCBs is 
inversely associated with fetal growth.
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